PL366123A1 - Nowe kompozycje farmaceutyczne zawierające epinastynę i pseudoefedrynę - Google Patents

Nowe kompozycje farmaceutyczne zawierające epinastynę i pseudoefedrynę

Info

Publication number
PL366123A1
PL366123A1 PL01366123A PL36612301A PL366123A1 PL 366123 A1 PL366123 A1 PL 366123A1 PL 01366123 A PL01366123 A PL 01366123A PL 36612301 A PL36612301 A PL 36612301A PL 366123 A1 PL366123 A1 PL 366123A1
Authority
PL
Poland
Prior art keywords
pseudoephedrine
pharmaceutical compositions
compositions containing
new pharmaceutical
containing epinastine
Prior art date
Application number
PL01366123A
Other languages
English (en)
Inventor
Sara Abelaira
Daniel Bianchi
Francisco Gel
Victor Denker
Mabel Fernandez
Marta Cicconi De Vidal
Original Assignee
Boehringer Ingelheim International Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=8170029&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL366123(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Boehringer Ingelheim International Gmbh filed Critical Boehringer Ingelheim International Gmbh
Publication of PL366123A1 publication Critical patent/PL366123A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A61P31/08—Antibacterial agents for leprosy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Otolaryngology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL01366123A 2000-10-06 2001-09-28 Nowe kompozycje farmaceutyczne zawierające epinastynę i pseudoefedrynę PL366123A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00121828 2000-10-06
PCT/EP2001/011229 WO2002028373A1 (en) 2000-10-06 2001-09-28 New pharmaceutical compositions containing epinastine and pseudoephedrine

Publications (1)

Publication Number Publication Date
PL366123A1 true PL366123A1 (pl) 2005-01-24

Family

ID=8170029

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01366123A PL366123A1 (pl) 2000-10-06 2001-09-28 Nowe kompozycje farmaceutyczne zawierające epinastynę i pseudoefedrynę

Country Status (32)

Country Link
EP (1) EP1326586B1 (pl)
JP (1) JP2004521864A (pl)
KR (1) KR20030036894A (pl)
CN (1) CN1291715C (pl)
AR (2) AR032479A1 (pl)
AT (1) ATE424813T1 (pl)
AU (2) AU2002212290B2 (pl)
BG (1) BG107686A (pl)
BR (1) BR0114339A (pl)
CA (1) CA2423288C (pl)
CZ (1) CZ2003945A3 (pl)
DE (1) DE60137952D1 (pl)
EA (1) EA007288B1 (pl)
EC (1) ECSP034513A (pl)
EE (1) EE200300138A (pl)
ES (1) ES2323570T3 (pl)
HK (1) HK1062196A1 (pl)
HR (1) HRP20030259A2 (pl)
HU (1) HUP0300970A3 (pl)
IL (1) IL154884A0 (pl)
ME (1) MEP39708A (pl)
MX (1) MXPA03002900A (pl)
MY (1) MY131159A (pl)
NO (1) NO20031537L (pl)
NZ (1) NZ525653A (pl)
PE (1) PE20020324A1 (pl)
PL (1) PL366123A1 (pl)
SK (1) SK4052003A3 (pl)
UA (1) UA75896C2 (pl)
WO (1) WO2002028373A1 (pl)
YU (1) YU24603A (pl)
ZA (1) ZA200302079B (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0210534A (pt) * 2001-06-20 2004-06-22 Schering Corp Anti-histaminas para o tratamento de congestão nasal e obstrução nasal
JP4549618B2 (ja) * 2001-11-22 2010-09-22 第一三共ヘルスケア株式会社 鼻炎用組成物
BR0313175A (pt) * 2002-08-02 2005-06-14 Boehringer Ingelheim Int Formulações farmacêuticas compreendendo combinações de epinastina, pseudoefedrina e metilefedrina
JP5021155B2 (ja) * 2003-08-01 2012-09-05 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング エピナスチンと１種以上のさらなる抗−ｈ１−ヒスタミン類との組合せを含む皮膚疾患治療用製薬組成物
WO2005079752A2 (en) * 2004-02-11 2005-09-01 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0903151A1 (en) * 1997-09-22 1999-03-24 ASTA Medica Aktiengesellschaft Use of combinations comprising non-sedating antihistamines and alpha-adrenergic drugs for the topical treatment of rhinitis/conjunctivitis and cold, cold-like and/or flu symptoms
CA2315721C (en) * 1997-12-23 2008-08-12 Schering Corporation Composition for treating respiratory and skin diseases, comprising at least one leukotriene antagonist and at least one antihistamine
CA2346227A1 (en) * 1998-10-09 2000-04-20 Schering Corporation Composition and method for treating allergic diseases
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
NO20031537D0 (no) 2003-04-04
CA2423288C (en) 2007-11-13
YU24603A (sh) 2006-05-25
WO2002028373A1 (en) 2002-04-11
HUP0300970A2 (hu) 2003-11-28
CZ2003945A3 (cs) 2003-08-13
AU2002212290B2 (en) 2006-08-03
EA007288B1 (ru) 2006-08-25
MEP39708A (en) 2011-02-10
AR032479A1 (es) 2003-11-12
CA2423288A1 (en) 2002-04-11
AR087240A2 (es) 2014-03-12
ECSP034513A (es) 2003-04-25
MY131159A (en) 2007-07-31
ATE424813T1 (de) 2009-03-15
BG107686A (bg) 2003-11-28
ZA200302079B (en) 2004-05-05
CN1468094A (zh) 2004-01-14
SK4052003A3 (en) 2003-09-11
AU1229002A (en) 2002-04-15
NZ525653A (en) 2006-07-28
IL154884A0 (en) 2003-10-31
EP1326586B1 (en) 2009-03-11
ES2323570T3 (es) 2009-07-21
DE60137952D1 (de) 2009-04-23
MXPA03002900A (es) 2003-09-10
KR20030036894A (ko) 2003-05-09
BR0114339A (pt) 2003-12-09
NO20031537L (no) 2003-06-04
HRP20030259A2 (en) 2005-02-28
HK1062196A1 (en) 2004-10-21
CN1291715C (zh) 2006-12-27
EA200300430A1 (ru) 2003-10-30
PE20020324A1 (es) 2002-06-18
EP1326586A1 (en) 2003-07-16
EE200300138A (et) 2003-08-15
HUP0300970A3 (en) 2005-03-29
JP2004521864A (ja) 2004-07-22
UA75896C2 (en) 2006-06-15

Similar Documents

Publication Publication Date Title
EG24357A (en) New Pharmaceutical composition
HUP0302385A3 (en) New multicyclic compounds and their use and pharmaceutical compositions containing them
HUP0302893A3 (en) Non-imidazole aryloxypiperidines and pharmaceutical compositions containing them and their use
HUP0204514A3 (en) Pyridinylimidazoles, pharmaceutical compositions containing them and their use
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
HK1075889A1 (en) Pharmaceutical composition
HUP0302297A3 (en) Substituted thioacetamides and pharmaceutical compositions containing them
IL150383A0 (en) Glyburide and pharmaceutical compositions containing the same
HUP0300698A3 (en) Composition containing n-acetyl-p-aminophenol
HK1057474A1 (en) Medicinal composition
IL153487A0 (en) Pharmaceutical compositions and methods for use
HUP0301582A3 (en) Calcilytic compounds and pharmaceutical compositions containing them
IL153897A0 (en) Pharmaceutical compositions and methods for use
HK1062196A1 (en) New pharmaceutical compositions containing epinastine and pseudoephedrine
HUP0203383A3 (en) Aminophenoxyacetamide derivatives and pharmaceutical composition containing thereof
IL151715A0 (en) N-deacetylthiocolchicine derivatives and pharmaceutical compositions containing them
AU8975701A (en) Novel composition and use
GB0013503D0 (en) Pharmaceutical compositions and their uses
GB0005382D0 (en) Pharmaceutical composition
IL135442A0 (en) Peptides and pharmaceutical compositions comprising them
AU2001294374A1 (en) 2-acylindenes and these containing perfume compositions
GB0002691D0 (en) Pharmaceutical composition
GB0101094D0 (en) Pharmaceutical composition
GB0014420D0 (en) Pharmaceutical compositions and their use
GB0013240D0 (en) Novel composition and use

Legal Events

Date Code Title Description
DISC Decisions on discontinuance of the proceedings (taken after the publication of the particulars of the applications)